BERKELEY HEIGHTS, N.J., Sept. 29, 2010 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP), a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today that Spiro Rombotis, President and Chief Executive Officer, will present at the 9th Annual BIO Investor Forum in San Francisco, California. Cyclacel's presentation will take place on Tuesday, October 5 at 3:00 p.m. Pacific Time.
